DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,716,800 | -25.2% | 80,000 | -53.9% | 0.41% | -19.8% |
Q1 2023 | $4,969,257 | -8.2% | 173,447 | 0.0% | 0.52% | -33.6% |
Q4 2022 | $5,411,546 | -50.2% | 173,447 | -67.6% | 0.78% | -47.4% |
Q3 2022 | $10,857,000 | -14.2% | 535,358 | -34.4% | 1.48% | -25.3% |
Q2 2022 | $12,660,000 | -32.7% | 815,740 | -17.1% | 1.98% | -18.7% |
Q1 2022 | $18,824,000 | -8.3% | 983,994 | +21.3% | 2.43% | +18.2% |
Q4 2021 | $20,525,000 | -28.8% | 810,940 | -7.8% | 2.06% | -54.2% |
Q3 2021 | $28,817,000 | – | 879,903 | – | 4.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |